SangeetaBhoradeMD
Pulmonology • Rochester, MNCritical Care Medicine, Pleural Disease
Associate Professor of Medicine, University of Chicago Medicine
Dr. Bhorade is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511Fax+1 312-695-6680
Education & Training
University of ChicagoFellowship, Pulmonary Disease and Critical Care Medicine, 1995 - 1998- University of ChicagoResidency, Internal Medicine, 1992 - 1995
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1992
Certifications & Licensure
IL State Medical License 1992 - 2026
MN State Medical License 2023 - 2024
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Early Indicators of Chronic Rejection in Lung Transplant Start of enrollment: 2006 Mar 01
- GI Reflux in Lung Transplant and Its Relationship to Chronic Rejection Start of enrollment: 2007 Jun 01
- Voriconazole as Prophylactic Therapy in Lung Transplant Recipients Start of enrollment: 2007 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 691 citationsSingle-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis.Paul A. Reyfman, James M. Walter, Nikita Joshi, Kishore R. Anekalla, Alexandra C. McQuattie-Pimentel
American Journal of Respiratory and Critical Care Medicine. 2019-06-15 - 669 citationsMonocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span.Alexander V. Misharin, Luisa Morales-Nebreda, Paul A. Reyfman, Carla M. Cuda, James M. Walter
The Journal of Experimental Medicine. 2017-08-07 - 443 citationsClinical risk factors for primary graft dysfunction after lung transplantationJoshua M. Diamond, James C. Lee, Steven M. Kawut, Rupal J. Shah, A. Russell Localio
American Journal of Respiratory and Critical Care Medicine. 2013-03-01
Other
- Induction immunosuppression following lung transplantationBhorade S, McShane PJ
http://www.uptodate.com/contents/induction-immunosuppression-following-lung-transplantation
UpToDate, Wolters Kluwer Health - 2012-05-14 - Maintenance immunosuppression following lung transplantationBhorade S, McShane PJ
http://www.uptodate.com/contents/maintenance-immunosuppression-following-lung-transplantation
UpToDate, Wolters Kluwer Health - 2012-07-26
Press Mentions
New Paper Highlights Utility of Natera’s Genetic Test Panel for Kidney Disease ManagementFebruary 3rd, 2023- Natera Supports Updated ISHLT Guidelines for the Care of Heart Transplant PatientsDecember 21st, 2022
- Natera Announces Enrollment Completion for RenaCARE StudyAugust 11th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
